In support of this notion, elevated expression of ST6Gal1 concurrently activated EGFR in the pancreatic cancer cell line Suit2, exhibiting higher invasion and elevated levels of mesenchymal markers (Britain et al., 2021). The gene discussed is ST6GAL1; the disease is pancreatic neoplasm.